We are live on ! Find out more
HW

Hancock Whitney Portfolio holdings

AUM $5.75B
1-Year Est. Return 24.3%
This Fund
S&P 500
This Quarter Est. Return
+8.4%
1 Year Est. Return
+24.3%
3 Year Est. Return
+81.4%
5 Year Est. Return
+108.63%
10 Year Est. Return
+431.68%
AUM
$3.13B
AUM Growth
+$188M
Cap. Flow
-$32M
Cap. Flow %
-1.02%
Top 10 Hldgs %
24.48%
Holding
868
New
96
Increased
234
Reduced
449
Closed
50

Top Buys

Rank Stock Value
1
STZ icon
Constellation Brands
STZ
+$18.6M
2
OSK icon
Oshkosh
OSK
+$15.7M
3
SYF icon
Synchrony
SYF
+$15.2M
4
MBB icon
iShares MBS ETF
MBB
+$13.7M
5
FHN icon
First Horizon
FHN
+$12.7M

Top Sells

Rank Stock Value
1
MKTX icon
MarketAxess Holdings
MKTX
+$15.9M
2
MNST icon
Monster Beverage
MNST
+$14.2M
3
PCAR icon
PACCAR
PCAR
+$11.3M
4
JPM icon
JPMorgan Chase
JPM
+$9.85M
5
AAPL icon
Apple
AAPL
+$9.68M

Sector Composition

Rank Sector Weight
1 Technology 17.2%
2 Financials 12.87%
3 Healthcare 10.57%
4 Industrials 9.68%
5 Consumer Discretionary 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHX icon
776
DHI Group
DHX
$166M
$137K ﹤0.01%
40,624
+2,152
+6% +$6.82K
DTIL icon
777
Precision BioSciences
DTIL
$188M
$134K ﹤0.01%
+357
New +$107K
HROW icon
778
Harrow
HROW
$1.43B
$134K ﹤0.01%
+14,451
New +$123K
NPTN
779
DELISTED
NEOPHOTONICS CORP
NPTN
$131K ﹤0.01%
12,811
+434
+4% +$4.58K
PROS
780
DELISTED
ProSight Global, Inc.
PROS
$129K ﹤0.01%
+10,115
New +$129K
TRUE
781
DELISTED
TrueCar
TRUE
$126K ﹤0.01%
22,328
-49
-0.2% -$247
SURF
782
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$123K ﹤0.01%
+16,449
New +$127K
SD icon
783
SandRidge Energy
SD
$510M
$122K ﹤0.01%
+19,419
New +$97.5K
ALR
784
DELISTED
AlerisLife Inc
ALR
$120K ﹤0.01%
+20,802
New +$118K
ULBI icon
785
Ultralife
ULBI
$88.3M
$117K ﹤0.01%
+13,977
New +$120K
VERU icon
786
Veru
VERU
$36.1M
$112K ﹤0.01%
+1,391
New +$123K
RES icon
787
RPC Inc
RES
$1.24B
$109K ﹤0.01%
22,000
GMBL
788
DELISTED
Esports Entertainment Group Inc. Common Stock
GMBL
0
MPU icon
789
Mega Matrix
MPU
$15.6M
$105K ﹤0.01%
+50,000
New +$101K
RNAC icon
790
Cartesian Therapeutics
RNAC
$232M
$104K ﹤0.01%
831
-6
-0.7% -$714
ELA icon
791
Envela
ELA
$536M
$101K ﹤0.01%
21,126
-155
-0.7% -$706
SIRI icon
792
SiriusXM
SIRI
$10B
$99K ﹤0.01%
1,508
RIGL icon
793
Rigel Pharmaceuticals
RIGL
$680M
$89K ﹤0.01%
2,044
+17
+0.8% +$642
GEOS icon
794
Geospace Technologies
GEOS
$91.6M
$88K ﹤0.01%
10,826
+332
+3% +$2.73K
JNCE
795
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$79K ﹤0.01%
+11,664
New +$96.9K
ARAY icon
796
Accuray
ARAY
$28.4M
$74K ﹤0.01%
16,293
+552
+4% +$2.58K
IMGN
797
DELISTED
Immunogen Inc
IMGN
$68K ﹤0.01%
+10,316
New +$72K
BDSI
798
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$64K ﹤0.01%
17,801
+999
+6% +$3.52K
AHCO icon
799
AdaptHealth
AHCO
$1.46B
-6,159
Closed -$226K
AMN icon
800
AMN Healthcare
AMN
$1.28B
-8,533
Closed -$629K

Similar funds

Hancock Whitney's Q2 2021 Portfolio in Review

As of Q2 2021, Hancock Whitney held 868 positions worth $3.13B, up 6.4% from $2.95B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Hancock Whitney's Q2 2021 filing shows 96 new, 234 increased, 449 reduced and 50 closed positions. Its largest new stake was Brandywine Realty Trust: 196,991 shares worth $2.7M. The largest sale was MarketAxess Holdings, an estimated $15.9M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Hancock Whitney's largest Q2 2021 buy was Brandywine Realty Trust: 196,991 shares worth $2.7M.
  • Hancock Whitney added most to Constellation Brands in Q2 2021, an estimated $18.6M increase.
  • Hancock Whitney's biggest Q2 2021 reduction was MarketAxess Holdings, cutting an estimated $15.9M.
  • Hancock Whitney fully exited Western Alliance Bancorporation in Q2 2021, selling an estimated $4.1M.
  • Hancock Whitney's ten largest holdings make up 24% of its $3.13B portfolio in Q2 2021.
  • Hancock Whitney opened 96 new positions and closed 50 in Q2 2021.
  • Hancock Whitney's portfolio value rose 6.4% quarter-over-quarter to $3.13B.

Based on Hancock Whitney's 13F filing for Q2 2021, filed 9 Aug 2021.